Cortagen: gene-expression and behavioral research limits
Cortagen is the synthetic tetrapeptide Ala–Glu–Asp–Pro. Its research includes mouse gene-expression and behavioral experiments. These findings do not establish improved memory, nerve repair or treatment of depression in people, and the similarly named Cortexin is a different mixture.
Identity and formulation
Cortagen is a defined four-amino-acid peptide; Cortexin is a polypeptide preparation. Findings for the mixture must not be assigned to the isolated peptide.
The final proline distinguishes AEDP from AED and AEDG. Short, similar sequences remain different compounds with different evidence.
What the studies show
The directly read studies are preclinical. One measured gene expression in mouse heart, and another compared behavioral responses in mice. A background sentence referring to prior human experience does not turn either experiment into a controlled human trial.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray.
Microarray analysis of heart tissue from female mice after Cortagen exposure Reading scope: PubMed abstract and bibliographic record; not full-text review |
Researchers reported changes in cardiac gene-expression profiles. | The tested tissue was heart, not a clinical cognitive endpoint. Changes in transcripts do not establish functional recovery or anti-aging benefit. |
| Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice (2009)
Controlled CD-1 mouse behavioral experiments comparing Cortagen and Cortexin Reading scope: Publisher PDF abstract and relevant methods/results text; not an exhaustive full-paper appraisal |
Cortagen altered locomotion and anxiety-related behaviors, with responses depending on exposure and timing. | More movement is not improved memory or recovery. Some conditions showed anxiety-like effects; mouse behavior cannot establish antidepressant benefit in people. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
How to interpret the findings
Gene-expression studies can generate hypotheses about mechanism. A changed transcript does not necessarily produce a useful protein change or a meaningful patient outcome.
Locomotor activity and anxiety-like behavior are separate experimental measures. More movement should not be rewritten as sharper cognition, and the direction of a behavioral response can depend on the testing condition.
The 2009 paper’s suggestion of a possible human application is a proposal for further investigation. It is not evidence of a clinical antidepressant effect.
Safety context
The behavioral work included anxiety-like responses under some conditions, so a blanket claim of emotional benefit or no behavioral side effects would overstate it.
Neither study establishes long-term human neurological safety or the effect of combining Cortagen with other agents.
Study exposure and units
The mouse behavioral paper found condition-dependent responses, which is one reason its exposures cannot be converted into a general human cognitive-enhancement schedule.
Keep the pure tetrapeptide and the extract comparator separate, including their units, formulation and timing. A ratio of animal exposures is not a human equivalence calculation.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Product identity and report checks
Verify the complete Ala–Glu–Asp–Pro sequence, termini and chemical form. A record for Cortexin, AED or AEDG does not authenticate Cortagen.
A pure-peptide assay cannot prove brain penetration, improved cognition or clinical nerve recovery. Those require separate experiments.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Common questions
Does the mouse heart study prove brain repair?
No. It investigated transcripts in cardiac tissue. A claim about memory, neural recovery or brain function needs directly relevant outcomes.
Can Cortexin studies substitute for Cortagen studies?
No. A mixture and a single synthetic peptide are not interchangeable, even when their names and development history are related.
Sources
- Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. (PubMed abstract and bibliographic record; not full-text review)
- Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice (2009) (Publisher PDF abstract and relevant methods/results text; not an exhaustive full-paper appraisal)